Rapid Micro Biosystems, Inc.
RPID
$1.57
-$0.04-2.48%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 35.18M | 34.38M | 33.59M | 30.52M | 30.29M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 35.18M | 34.38M | 33.59M | 30.52M | 30.29M |
| Cost of Revenue | 33.23M | 33.37M | 32.54M | 28.17M | 28.01M |
| Gross Profit | 1.95M | 1.01M | 1.05M | 2.36M | 2.28M |
| SG&A Expenses | 38.27M | 37.26M | 34.84M | 33.98M | 34.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 84.93M | 83.97M | 80.98M | 75.93M | 76.37M |
| Operating Income | -49.76M | -49.58M | -47.39M | -45.41M | -46.08M |
| Income Before Tax | -51.13M | -50.09M | -47.08M | -44.28M | -44.09M |
| Income Tax Expenses | 75.00K | 41.00K | 40.00K | 17.00K | 22.00K |
| Earnings from Continuing Operations | -51.20 | -50.14 | -47.12 | -44.29 | -44.11 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -51.20M | -50.14M | -47.12M | -44.29M | -44.11M |
| EBIT | -49.76M | -49.58M | -47.39M | -45.41M | -46.08M |
| EBITDA | -47.08M | -46.87M | -44.64M | -42.48M | -43.09M |
| EPS Basic | -1.12 | -1.12 | -1.06 | -1.00 | -1.00 |
| Normalized Basic EPS | -0.70 | -0.70 | -0.66 | -0.62 | -0.63 |
| EPS Diluted | -1.12 | -1.12 | -1.06 | -1.00 | -1.00 |
| Normalized Diluted EPS | -0.70 | -0.70 | -0.66 | -0.62 | -0.63 |
| Average Basic Shares Outstanding | 183.36M | 179.66M | 178.22M | 177.37M | 176.08M |
| Average Diluted Shares Outstanding | 183.36M | 179.66M | 178.22M | 177.37M | 176.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |